What is Trifecta?
Based in Los Angeles, Trifecta operates as a critical infrastructure provider for the pharmaceutical and biotech industries. The company specializes in a comprehensive suite of clinical trial solutions, ranging from on-demand investigator training and live production services to automated study close-out procedures. By digitizing complex workflows such as site start-up document exchange and safety letter distribution, Trifecta effectively reduces the administrative burden on clinical research sites. This operational efficiency is essential for sponsors aiming to shorten development timelines and ensure rigorous compliance across global study portfolios.
How much funding has Trifecta raised?
Trifecta has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Trifecta
PPP
Public-Private Partnership
What's next for Trifecta?
With this major strategic investment, Trifecta is poised to transition into a new phase of enterprise-level growth. The company is expected to leverage this capital to enhance its automated study management platforms, potentially integrating advanced analytics to further streamline site performance. As the demand for decentralized and hybrid clinical trials continues to rise, Trifecta's focus on scalable, web-based investigator engagement tools will likely become a cornerstone of its long-term market strategy. Future initiatives will likely prioritize the expansion of its digital ecosystem to support increasingly complex, multi-site global trials, solidifying its position as an indispensable partner in the drug development lifecycle.
See full Trifecta company page
